4.7 Review

Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities

Journal

BIOORGANIC CHEMISTRY
Volume 142, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2023.106934

Keywords

C-Src; Tyrosine protein kinase (TKs); Small-molecule inhibitors; Therapeutic utilities

Ask authors/readers for more resources

This review summarizes the important role of c-Src kinase in cell division, motility, adhesion, and survival, as well as its implications in disease. It provides valuable insights and new ideas for researchers in areas such as inhibitor development, combination therapy, and clinical research.
Proto-oncogene tyrosine-protein kinase Src, also known as c-Src, belongs to the family of non-receptor tyrosine protein kinases (TKs) called Src kinases. It plays a crucial role in cell division, motility, adhesion, and survival in both normal cells and cancer cells by activating various signaling pathways mediated by multiple cytokines. Additionally, c-Src kinase has been implicated in osteoclasts and bone loss diseases mediated by inflammation and osteoporosis. In recent years, remarkable advancements have been achieved in the development of c-Src inhibitors, with several candidates progressing to the clinical stage. This review focuses on the research progress in several areas, including the mechanism of action, drug discovery, combination therapy, and clinical research. By presenting this information, we aim to provide researchers with convenient access to valuable insights and inspire new ideas to expedite future drug discovery programs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available